SCHEMBL24326409

SCHEMBL24326409

CC(C)(C)OC(=O)N1CCCN(Sc2ccccc2[N+](=O)[O-])CC(O)C1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
PKM P14618 1/20 0.43
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MMP1 P03956 1/20 0.38
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38
BTK Q06187 2/20 0.38
MAPK1 P28482 2/20 0.38
MET P08581 1/20 0.38
USP30 Q70CQ3 2/20 0.37
P2RX3 P56373 1/20 0.37
KMT2A Q03164 2/20 0.36
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
MEN1 O00255 1/20 0.36
NR1D1 P20393 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24326472 0.84 MAPT (0.58) MAPTPKMALDH1A1LMNAMAPK1
SCHEMBL21035869 0.79 MAPT (0.46) MAPTPKMALDH1A1LMNAMAPK1
SCHEMBL29570525 0.78 MEN1 (0.57) MAPTPKMALDH1A1LMNAMMP1
SCHEMBL27012162 0.78 MEN1 (0.57) MAPTPKMALDH1A1LMNAMMP1
SCHEMBL29570638 0.74 MET (0.52) MAPTPKMALDH1A1LMNAMET
SCHEMBL24326075 0.74 USP30 (0.38) PKMALDH1A1MMP1MMP9USP30
SCHEMBL14990419 0.72 ROCK2 (0.50) ALDH1A1LMNAMMP1MMP9MMP13
SCHEMBL14990420 0.72 ROCK2 (0.50) ALDH1A1LMNAMMP1MMP9MMP13
SCHEMBL744261 0.71 USP30 (0.54) MAPTALDH1A1LMNABTKMAPK1
SCHEMBL744262 0.71 USP30 (0.54) MAPTALDH1A1LMNABTKMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed